LI
ONC

Leap Investments’s BeOne Medicines Ltd ONC Stock Holding History

Leap Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,800
Closed -$1.46M – 591
2019
Q4 		$1.46M Buy
+8,800
New +$1.46M 0.68% 27

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Leap Investments's ONC Position: Q1 2020 in Review

Leap Investments sold out of BeOne Medicines Ltd (ONC) in Q1 2020, closing a stake of 8,800 shares — an estimated $1.46M sold.

Leap Investments first reported a position in ONC in Q4 2019 and held it in 1 quarter. The position peaked at $1.46M in Q4 2019. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

  • Leap Investments reported no remaining BeOne Medicines Ltd position as of Q1 2020 after selling out during the quarter.
  • Leap Investments sold 8,800 BeOne Medicines Ltd shares in Q1 2020, an estimated $1.46M.
  • Leap Investments first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 1 quarter.
  • Leap Investments's BeOne Medicines Ltd position peaked at $1.46M in Q4 2019.
  • 215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.